Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06284343 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Gynecological Cancer Associated Thrombosis (GynCAT) Study

Study acronym: GynCAT
StatusUnknown
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated September 19, 2024 (before its estimated September 30, 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Changed Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
  2. Trial status: Not Yet Recruiting to Recruitingv2 Show 6 more changesShow less
    • Primary endpoint revised
    • Start date changed from estimate of Apr 1, 2024 to Apr 15, 2024
    • Secondary endpoint revised
    • Study description expanded, about 436 words
    • Study site revised
    • Study title shortened, about 19 words
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
GynCAT is a prospective cohort study that will be conducted on female patients with gynecologic malignancies scheduled for systemic antineoplastic treatment, aiming at development and validation of a Risk Assessment Model (RAM) for Venous Thromboembolism (VTE) in this specific population.
Trial Details
NCT Number NCT06284343
Lead Sponsor Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Collaborators: Fondazione Umberto Veronesi
Conditions
(from sponsor)		 Cancer-associated Thrombosis, Venous Thromboembolism, Gynecologic Cancer, Ovarian Cancer, Cervix Cancer, Endometrial Cancer, Vaginal Cancer
Related terms Endometrial Neoplasms, Neoplasms, Ovarian Neoplasms, Thrombosis, Uterine Cervical Neoplasms, Vaginal Neoplasms, Venous Thromboembolism
Enrollment 1,800 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov